Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Rockwell Medical

What Analysts Are Saying About Rockwell Medical Stock

Ratings for Rockwell Medical (NASDAQ:RMTI) were provided by 4 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.

Benzinga · Nov 25, 2024

AIM ImmunoTech Issues Presentation Detailing Case For Re-Electing Current Directors To Oversee Continued Momentum And Drive Strategy To Create Long-Term Value For Patients And Shareholders; Warns Shareholders Of Its Belief That The Activist Group And Its Nominees Have A Self-Interested Agenda And Could Put AIM's Clinical Progress At Risk

Highlights How Positive Data in AIM's Clinical Pipeline and Big Pharma Partnerships are Positioning the Company for Commercialization Opportunities in High-Value Indications Including Pancreatic CancerWarns Shareholders

Benzinga · Nov 25, 2024

12 Health Care Stocks Moving In Friday's Intraday Session

Benzinga · Jul 22, 2022

From analysis to the latest developments in health,
read the most diverse news in one place.

Rockwell Medical Receives Additional FDA Feedback On Anemia Candidate

Last week, Rockwell Medical Inc (NASDAQ:RMTI) closed the second $7.5 million tranche of the previously announced DaVita Inc (NYSE:DVA) stock purchase agreement of up to $15 million in convertible preferred stock in two tranches. This investment, in addition to the recently announced $15 million financings, brings the total gross amount raised by Rockwell this quarter to $30 million. …

Benzinga · Jun 23, 2022

Recap: Rockwell Medical Q1 Earnings

Rockwell Medical (NASDAQ:RMTI) reported its Q1 earnings results on Monday, May 16, 2022 at 04:00 PM. Here's what investors need to know about the announcement.

Benzinga · May 16, 2022

Preview: Rockwell Medical's Earnings

Rockwell Medical (NASDAQ:RMTI) is set to give its latest quarterly earnings report on Monday, 2022-05-16. Here's what investors need to know before the announcement. Analysts estimate that Rockwell Medical will report an earnings per share (EPS) of $-0.09.

Benzinga · May 13, 2022

Rockwell Medical Submits Additional Data For IND Application For Iron Deficiency Candidate

Rockwell Medical Inc (NASDAQ:RMTI) has provided the FDA with the supplemental data requested by the agency in December 2021 for its pending Investigational New Drug (IND) application of Ferric Pyrophosphate Citrate (FPC) for iron deficiency. The IND supports the proposed Phase 2 trial of FPC for treating iron deficiency anemia and maintaining hemoglobin…

Benzinga · May 12, 2022

Read news from The Economist, FT, and more,
with one subscription

Rockwell Medical's Return On Capital Employed Insights

Benzinga Pro data, Rockwell Medical (NASDAQ:RMTI) reported Q4 sales of $15.33 million. Earnings fell to a loss of $8.94 million, resulting in a 17.94% decrease from last quarter.

Benzinga · Apr 11, 2022

Coverage From

Benzinga

Organisations

HTG Molecular Diagnostics

10 stories

VistaGen rapeutics

10 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Topics

Read news from The Economist, FT, and more,
with one subscription

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.